127.20
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $127.20, with a volume of 1.82M.
It is down -0.13% in the last 24 hours and up +4.63% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$127.37
Open:
$127.35
24h Volume:
1.82M
Relative Volume:
0.85
Market Cap:
$30.98B
Revenue:
$222.16B
Net Income/Loss:
$1.31B
P/E Ratio:
23.73
EPS:
5.36
Net Cash Flow:
$-486.00M
1W Performance:
+1.49%
1M Performance:
+4.63%
6M Performance:
+26.35%
1Y Performance:
+21.20%
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CAH
Cardinal Health Inc
|
127.20 | 30.98B | 222.16B | 1.31B | -486.00M | 5.36 |
![]()
MCK
Mckesson Corporation
|
603.40 | 75.62B | 344.58B | 2.83B | 1.63B | 21.84 |
![]()
COR
Cencora Inc
|
246.38 | 47.78B | 303.19B | 1.40B | -638.10M | 7.03 |
![]()
HSIC
Henry Schein Inc
|
78.90 | 9.32B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
PDCO
Patterson Companies Inc
|
31.01 | 2.72B | 6.55B | 155.22M | -823.13M | 1.71 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Dec-04-24 | Resumed | Mizuho | Outperform |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Feb-09-24 | Upgrade | Argus | Hold → Buy |
Jan-03-24 | Initiated | Barclays | Overweight |
Dec-14-23 | Initiated | Wells Fargo | Underweight |
Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
Mar-31-23 | Initiated | Citigroup | Neutral |
Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
Aug-22-22 | Resumed | Morgan Stanley | Overweight |
May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Apr-01-22 | Resumed | Credit Suisse | Neutral |
Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
May-15-20 | Upgrade | UBS | Neutral → Buy |
Apr-23-20 | Resumed | Credit Suisse | Neutral |
Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
Sep-12-19 | Initiated | Deutsche Bank | Hold |
Aug-27-19 | Downgrade | Argus | Buy → Hold |
Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
Apr-18-19 | Initiated | Guggenheim | Neutral |
Jan-17-19 | Initiated | UBS | Neutral |
Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
Apr-02-18 | Upgrade | Argus | Hold → Buy |
Mar-08-18 | Initiated | Barclays | Equal Weight |
Feb-27-18 | Resumed | BofA/Merrill | Underperform |
Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Cardinal Health, Inc. completed the acquisition of 73% stake in The GI Alliance Management, LLC from GIA physician owners and funds managed by affiliates of Apollo Global Management, Inc.. - Marketscreener.com
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056 - Yahoo Finance
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
Miller Howard Investments Inc. NY Takes $573,000 Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Entropy Technologies LP Invests $1.60 Million in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Are Wall Street Analysts Predicting Cardinal Health Stock Will Climb or Sink? - TradingView
Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Tobam - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Increases Stock Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health (NYSE:CAH) Upgraded by Jefferies Financial Group to Buy Rating - MarketBeat
Bleakley Financial Group LLC Purchases 6,501 Shares of Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Avitas Wealth Management LLC Makes New $1.47 Million Investment in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
With 88% ownership in Cardinal Health, Inc. (NYSE:CAH), institutional investors have a lot riding on the business - Yahoo Finance
abrdn plc Trims Stock Holdings in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health (NYSE:CAH) Price Target Raised to $136.00 at Wells Fargo & Company - MarketBeat
Cardinal Health (NYSE:CAH) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Yousif Capital Management LLC Has $13.08 Million Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Columbus Macro LLC Increases Stock Holdings in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health, Inc. Declares Quarterly Dividend of $0.51 (NYSE:CAH) - MarketBeat
Cardinal Health's (NYSE:CAH) Dividend Will Be $0.5056 - Simply Wall St
Cardinal Health Q3 EPS Forecast Lowered by Leerink Partnrs - MarketBeat
Spire Wealth Management Purchases 5,733 Shares of Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Pharmaceuticals Wholesale & Distribution Market to grow by USD 896.5 Billion from 2024-2028, Driven by Growing Global Pharmaceutical Sales, Report on How AI is Driving Market Transformation - Benzinga
Burford Brothers Inc. Acquires Shares of 10,617 Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Stock Yards Bank & Trust Co. Reduces Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health raised to buy by Jefferies - MSN
Cardinal Health raises FY25 EPS guidance to $7.85-$8 amid specialty growth and acquisitions - MSN
Avantra Family Wealth Inc. Invests $881,000 in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health raised to buy by Jefferies (CAH:NYSE) - Seeking Alpha
Cardinal Health to Open New Distribution Center in Ft. Worth - Construction Equipment Guide
Radioactive Tracer Market Generated Opportunities, Future Scope by 2032 | PerkinElmer Inc., Cardinal Health, - EIN News
This NXP Semiconductors Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Jefferies Upgrades Cardinal Health to Buy From Hold, Adjusts Price Target to $150 From $140 - Marketscreener.com
Cardinal Health’s Growth Potential Under New Management: Buy Rating Backed by Strong Earnings and Strategic Acquisitions - TipRanks
Cardinal Health (NYSE:CAH) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
Independence Bank of Kentucky Buys 3,200 Shares of Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Kingswood Wealth Advisors LLC Invests $315,000 in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health Sees Unusually Large Options Volume (NYSE:CAH) - MarketBeat
Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings - Benzinga
JPMorgan Adjusts Price Target on Cardinal Health to $145 From $142, Maintains Neutral Rating - Marketscreener.com
Cardinal Health Second Quarter 2025 Earnings: EPS Beats Expectations - Simply Wall St
A fourth Dublin high school? District exploring purchasing part of Cardinal Health HQ - AOL
IntelBroker Strikes HPE Again, Cardinal Health Breach, and U.S. ISP Root Access Sale - SOCRadar
Healthcare Distribution Market Set to Witness Significant Growth by 2025-2032: Consorta, Inc., Cardinal - EIN News
Mediolanum International Funds Ltd Increases Holdings in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Sivik Global Healthcare LLC Has $5.91 Million Stake in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health (NYSE:CAH) Posts Quarterly Earnings Results, Beats Expectations By $0.19 EPS - MarketBeat
Pacer Advisors Inc. Has $4.28 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat
Cardinal Health Keeps Quarterly Dividend at $0.5056 a Share, Payable April 15 to Investors of Record April 1 - Marketscreener.com
Cardinal Health Board of Directors Approves Quarterly Dividend - Quantisnow
Dublin City Schools cancels plan to buy Cardinal Health building for $37 million - NBC4 WCMH-TV
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):